Arterial Blood Pressure. Hypertension (arterial)(benign)(essential)(malignant)(primary)(systemic)
Conditions
Interventions
Intervention 1: Intervention group:Patients without or with hypertension class I-II at age 40-70. Intervention 2: Control group: Patients without or with hypertension class I-II at age 40-70 receiving
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: normotensive Patients Stage I-II hypertensive patients patients at age 40-70
Exclusion criteria
Exclusion criteria: Difficult intubation BMI more than 30 Patient receiving Clonidine Pregnancy Laryngoscopy more than 20 seconds Emergency surgery Patients with heart blocks ASA class III and more Patients with pheochromocytoma Patients with thyroid disorders Patients with neuropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: At time zero(basic hemodynamics),T1(5 minutes after drug or placebo injection),T2(after induction of general anesthesia) T3(one minute after tracheal intubation),T4(3 minutes after intubation) T5(5 minutes after intubation) T6( 10 minutes after intubation). Method of measurement: Measuring using electronic cardiovascular monitoring device.;Diastolic blood pressure. Timepoint: At time zero(basic hemodynamics),T1(5 minutes after drug or placebo injection),T2(after induction of general anesthesia) T3(one minute after tracheal intubation),T4(3 minutes after intubation) T5(5 minutes after intubation) T6( 10 minutes after intubation). Method of measurement: Measuring using electronic cardiovascular monitoring device.;Mean arterial pressure. Timepoint: At time zero(basic hemodynamics),T1(5 minutes after drug or placebo injection),T2(after induction of general anesthesia) T3(one minute after tracheal intubation),T4(3 minutes after intubation) T5(5 minutes after intubation) T6( 10 minutes after intubation). Method of measurement: Measuring using electronic cardiovascular monitoring device.;Heart rate. Timepoint: At time zero(basic hemodynamics),T1(5 minutes after drug or placebo injection),T2(after induction of general anesthesia) T3(one minute after tracheal intubation),T4(3 minutes after intubation) T5(5 minutes after intubation) T6( 10 minutes after intubation). Method of measurement: Measuring using electronic cardiovascular monitoring device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hypnotic drug(propofol) induction dose in patients with hypertensive disease. Timepoint: At the end of anesthesia induction. Method of measurement: Propofol dose needed for induction of anesthesia as milligram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahram Shokohi
Oroumia University of Medical Sciences
Outcome results
None listed